Archive for the News Category

Ceapro Announces $370,000 of Convertible Debentures Converted to Equity

EDMONTON, ALBERTA, Canada —January 3, 2012 — Ceapro Inc. (TSX-V CZO) today announced that holders of $370,000 of the convertible debentures due December 31, 2011 have elected to convert their debentures into common shares at a conversion price of 10 cents per common share. This will result

Read more

Ceapro provides Update to Shareholders

Edmonton, AB–(Marketwire – December 6, 2011) – The following is a letter to shareholders from Ceapro Inc. Dear Shareholders: At Ceapro (TSXV: CZO) we are very pleased with our year to date 2011 financial results showing profitability and continuous improvement in our balance sheet. Significantly these results

Read more

Ceapro Reports Third Quarter 2011 Financial Results

EDMONTON, ALBERTA –November 29, 2011 – Ceapro Inc. (CZO TSX–V) (“Ceapro” or the Company”) today announced its financial results for the three-month and nine-month periods ended September 30, 2011. These results are presented in accordance with the International Financial Reporting Standards (IFRS) of the International Accounting Standards

Read more

Ceapro Announces Signing of a Sales Agreement With Ross Organic Specialty Sales Inc. for its certified All-Natural Active Ingredients in the Western United States

EDMONTON, ALBERTA–(Marketwire – October 12, 2011) – Ceapro Inc. (TSX VENTURE:CZO) (“Ceapro” or “the Company”) is pleased to announce today the signing of a new sales agreement with California based company, Ross Organic Specialty Sales Inc. The agreement encompasses Ceapro’s entire range of Ecocert™ certified all-natural active

Read more

Ceapro Files Statement of Defence

Edmonton, Alberta –September 29, 2011 – Ceapro Inc. (CZO – TSX Venture) (“Ceapro” or the Company”) announced today it and its wholly owned subsidiary, Ceapro Veterinary Products Inc., have filed a Statement of Defence in the Court of Queens Bench of Alberta to defend claims made by

Read more

Ceapro Defends Claim from AVAC Ltd.

Edmonton, Alberta –September 13, 2011 – Ceapro Inc. (CZO – TSX Venture) (“Ceapro” or the Company”) announced today it and its wholly owned subsidiary, Ceapro Veterinary Products Inc., were served with a Statement of Claim filed in the Court of Queens Bench of Alberta by AVAC Ltd.

Read more

Ceapro Reports Second Quarter 2011 Financial Results

EDMONTON, ALBERTA–(Marketwire – Aug. 10, 2011) – Ceapro Inc. (TSX VENTURE:CZO)(“Ceapro” or the Company”) today announced its financial results as at and for the three-month and the six-month periods ended June 30, 2011. These results are presented in accordance with the International Financial Reporting Standards (IFRS) of

Read more

Ceapro Announces Re-election of Board and Grant of Stock Options

EDMONTON, ALBERTA, CANADA–(Marketwire – June 28, 2011) -Ceapro Inc. (TSX VENTURE:CZO) today announced that Motions carried at the Annual General Meeting of June 23, 2011 include the re-election of Board Members: Ed Taylor as Chairman, Gilles Gagnon, Don Oborowsky, Glenn Rourke, and John Zupancic. Gilles Gagnon was

Read more

Ceapro Reports Record Profit and Record Revenues for First Quarter 2011

EDMONTON, ALBERTA–(Marketwire – June 20, 2011) – Ceapro Inc. (TSX VENTURE:CZO) (“Ceapro” or the Company”) today announced its financial results for the first quarter ended March 31, 2011. These results are presented in accordance with the International Financial Reporting Standards (IFRS) of the International Accounting Standards Board (IASB). FIRST

Read more

Ceapro Announces New Collaboration and Funding Agreement Targeting Novel High Value Active Ingredients

EDMONTON, ALBERTA–(Marketwire – June 14, 2011) – Ceapro Inc. (TSX VENTURE:CZO) today announced that it has entered into a Material Transfer Agreement (MTA) with the National Research Council of Canada (NRC) to evaluate a new series of potentially high-value active ingredients from a variety of rosehips uniquely

Read more
Page 10 of 11« First...7891011